Phil, Inc. raises $60M for AI-powered therapy deployment

Today we announced a $60 million growth debt financing for Phil, Inc., a software-powered therapy deployment platform transforming how pharmaceutical manufacturers tackle access, affordability, and distribution. This funding will fuel Phil’s expansion and fast-track the integration of AI across its platform—helping bring therapies to patients faster and more efficiently across a wide range of conditions. http://bit.ly/45UR6fV